SCHEMBL3629732

SCHEMBL3629732

CC[C@H](C)[C@H](NC(C)=O)C(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CTSS P25774 1/20 0.39
▸ CTSK P43235 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ MME P08473 2/20 0.38
▸ ACE P12821 2/20 0.38
▸ CPA1 P15085 2/20 0.38
▸ ACE2 Q9BYF1 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ GZMB P10144 2/20 0.37
▸ ANPEP P15144 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30425416 0.82 OPRD1 (0.39) ALDH1A1MME
SCHEMBL2787269 0.82 GZMB (0.49) MEN1KMT2ASMN1; SMN2GZMB
SCHEMBL12149992 0.82 ENPEP (0.42) —
SCHEMBL22860748 0.81 PSMB5 (0.44) MEN1KMT2ASMN1; SMN2
SCHEMBL29434612 0.81 ALDH1A1 (0.54) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL30493640 0.81 MME (0.57) MEN1KMT2ASMN1; SMN2ALDH1A1CTSS
SCHEMBL32679433 0.80 DPP8 (0.41) —
SCHEMBL31411848 0.78 CTSD (0.54) MME
SCHEMBL30563311 0.77 TERT (0.40) ALDH1A1MMEACECPA1ACE2
SCHEMBL15692297 0.77 ALDH1A1 (0.58) MEN1KMT2ASMN1; SMN2ALDH1A1MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225388-A1 COMPOSITIONS FOR FORMING IMMOBIIZED BIOLOGICAL LAYERS FOR SENSING Abbott Point Of Care, Inc. (US) 2010-09-08 — — EP disclosed
WO-2009082699-A1 COMPOSITIONS FOR FORMING IMMOBIIZED BIOLOGICAL LAYERS FOR SENSING I-STAT CORPORATION (US) 2009-07-02 — — WO disclosed
Send feedback